JAYME DURBIN: Open Payments
NPI 1568125631 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,099 in 145 payments from 26 companies in 2025. Trend: 2023 $2,164 · 2024 $2,966 · 2025 $3,099
Food & beverage: $3,099
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $518 |
| Novartis Pharmaceuticals Corporation | 19 | $404 |
| ABBVIE INC. | 19 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $326 |
| ANI Pharmaceuticals, Inc. | 10 | $196 |
| Grifols USA, LLC | 10 | $168 |
| SK Life Science, Inc. | 7 | $153 |
| JAZZ PHARMACEUTICALS INC. | 6 | $140 |
| ARGENX US, INC. | 5 | $139 |
| CSL Behring | 4 | $87 |
Products named: KESIMPTA, HYQVIA, Fintepla, Rystiggo, PURIFIED CORTROPHIN GEL, Gamunex-C, BOTOX, EPIDIOLEX.
Industry payments across TX — which companies pay providers there.
